{"log_id": 7214412113098773767, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.030213, "average": 0.826174, "min": 0.531711}, "location": {"width": 621, "top": 105, "height": 27, "left": 403}, "words": " ng,Ig PI cn-truth approved 20160421(ref SMPC 20140605) renewal"}, {"probability": {"variance": 0.001276, "average": 0.984114, "min": 0.883616}, "location": {"width": 264, "top": 219, "height": 29, "left": 208}, "words": "非小细胞肺癌( NSCLC)"}, {"probability": {"variance": 0.000144, "average": 0.993378, "min": 0.937417}, "location": {"width": 777, "top": 274, "height": 29, "left": 246}, "words": "两项随机临床研究(共657例患者)结果支持应用吉西他滨联合顺铂一线治"}, {"probability": {"variance": 2.9e-05, "average": 0.995848, "min": 0.978934}, "location": {"width": 361, "top": 322, "height": 30, "left": 203}, "words": "疗局部晚期或转移性非小细胞肺癌"}, {"probability": {"variance": 0.011848, "average": 0.956506, "min": 0.599691}, "location": {"width": 291, "top": 384, "height": 32, "left": 205}, "words": "青西他滨联合顺铂对比顺铂"}, {"probability": {"variance": 0.00015, "average": 0.996357, "min": 0.92776}, "location": {"width": 777, "top": 447, "height": 33, "left": 245}, "words": "第一项在欧洲、美国、加拿大进行的临床研究,共治疗了522例不能手术的"}, {"probability": {"variance": 0.012701, "average": 0.949572, "min": 0.442991}, "location": {"width": 792, "top": 495, "height": 30, "left": 205}, "words": "IA、IB、IV期非小细胞肺癌患者。吉西他滨10mg/m2,第1,8,15天给药"}, {"probability": {"variance": 0.005933, "average": 0.975705, "min": 0.589189}, "location": {"width": 817, "top": 541, "height": 30, "left": 204}, "words": "顺铂100mg/m2,第1天给药,每28天为一周期;单药顺铂为100mg/m2,第1天给"}, {"probability": {"variance": 0.005838, "average": 0.9796, "min": 0.5497}, "location": {"width": 820, "top": 588, "height": 30, "left": 201}, "words": "药,每28天为一周期。主要的观察终点为生存。患者的情况见表4。两组患者的"}, {"probability": {"variance": 8.8e-05, "average": 0.995804, "min": 0.954451}, "location": {"width": 700, "top": 635, "height": 28, "left": 202}, "words": "组织学分布不平衡,顺铂组有48%而吉西他滨组37%的患者为腺癌"}, {"probability": {"variance": 0.003905, "average": 0.97792, "min": 0.665271}, "location": {"width": 779, "top": 697, "height": 32, "left": 242}, "words": " Kaplan- Meier/生存曲线见图3。吉西他滨联合顺铂对比单药顺铂,中位生存"}, {"probability": {"variance": 0.00855, "average": 0.970406, "min": 0.552773}, "location": {"width": 820, "top": 745, "height": 29, "left": 201}, "words": "时间是9.0个月对比7.6个月( Log rank p-0.008,双侧检验),中位疾病进展时间"}, {"probability": {"variance": 0.003248, "average": 0.978548, "min": 0.667845}, "location": {"width": 817, "top": 792, "height": 30, "left": 203}, "words": "是5.2月对比3.7月( Log rank p=0.009,双侧检验)。吉西他滨联合顺铂与顺铂"}, {"probability": {"variance": 0.0058, "average": 0.967654, "min": 0.597634}, "location": {"width": 788, "top": 840, "height": 29, "left": 203}, "words": "单药组的客观缓解率为26%对比10%( Fisher精确检验p0.0001,双侧检验"}, {"probability": {"variance": 0.000536, "average": 0.989877, "min": 0.914528}, "location": {"width": 334, "top": 885, "height": 30, "left": 203}, "words": "两组间疾病缓解持续时间无差异"}, {"probability": {"variance": 0.002248, "average": 0.918307, "min": 0.870896}, "location": {"width": 189, "top": 861, "height": 102, "left": 599}, "words": "贸易"}, {"probability": {"variance": 0.010413, "average": 0.959271, "min": 0.584025}, "location": {"width": 481, "top": 949, "height": 38, "left": 203}, "words": "吉西他滨联合顺铂对比依托泊苷联合顺链"}, {"probability": {"variance": 0.008671, "average": 0.973182, "min": 0.479381}, "location": {"width": 778, "top": 1011, "height": 32, "left": 244}, "words": "第二项多中心、随机临床研究治疗了135例B或ⅣV期 NSCLC患者。吉"}, {"probability": {"variance": 0.008366, "average": 0.961562, "min": 0.529634}, "location": {"width": 818, "top": 1059, "height": 30, "left": 202}, "words": "西他滨1250mg/m,第1、8天;顺铂100mg/m2,第1天,每21天为一周期或"}, {"probability": {"variance": 0.019846, "average": 0.910729, "min": 0.503079}, "location": {"width": 666, "top": 1107, "height": 29, "left": 203}, "words": "依托泊苷100mg/m2I.V,第1.23天;顺铂100mg/m第1天,每"}, {"probability": {"variance": 0.100948, "average": 0.681748, "min": 0.364026}, "location": {"width": 178, "top": 1105, "height": 104, "left": 860}, "words": "公"}, {"probability": {"variance": 0, "average": 0.996124, "min": 0.995515}, "location": {"width": 53, "top": 1108, "height": 27, "left": 969}, "words": "周期"}, {"probability": {"variance": 0.027045, "average": 0.882788, "min": 0.650216}, "location": {"width": 71, "top": 1156, "height": 28, "left": 226}, "words": "见表4"}, {"probability": {"variance": 0.01603, "average": 0.949339, "min": 0.422909}, "location": {"width": 554, "top": 1216, "height": 30, "left": 243}, "words": "两组间生存期无显著差异( Log rank . p=0.18,双侧检验"}, {"probability": {"variance": 6e-06, "average": 0.997252, "min": 0.993609}, "location": {"width": 142, "top": 1218, "height": 28, "left": 878}, "words": "他联合顺铂"}, {"probability": {"variance": 0.000907, "average": 0.983915, "min": 0.894069}, "location": {"width": 603, "top": 1264, "height": 29, "left": 200}, "words": "组的中位生存时间为8.7个月,依托泊苷联合顺铂组为7.0"}, {"probability": {"variance": 3.6e-05, "average": 0.991928, "min": 0.985908}, "location": {"width": 47, "top": 1265, "height": 29, "left": 973}, "words": "进展"}, {"probability": {"variance": 0.004804, "average": 0.967778, "min": 0.676332}, "location": {"width": 818, "top": 1312, "height": 29, "left": 199}, "words": "时间为5.0个月对比4.1个月( Log rank,p=0.015,双侧检验),客观解率33%"}, {"probability": {"variance": 0.010561, "average": 0.953693, "min": 0.536451}, "location": {"width": 516, "top": 1359, "height": 30, "left": 202}, "words": "对比14%( fisher'精确检验,p=0.01,双侧检验)"}, {"probability": {"variance": 0.018358, "average": 0.913949, "min": 0.642568}, "location": {"width": 186, "top": 1423, "height": 27, "left": 203}, "words": "生活质量(QOL):"}, {"probability": {"variance": 0.046161, "average": 0.886561, "min": 0.456938}, "location": {"width": 236, "top": 1392, "height": 81, "left": 777}, "words": "有限公司月"}, {"probability": {"variance": 0.017025, "average": 0.950456, "min": 0.35331}, "location": {"width": 778, "top": 1484, "height": 31, "left": 241}, "words": "生活质量是这两项临床研究的次要研究终点。在吉西他滨对比顺铂"}, {"probability": {"variance": 0.008133, "average": 0.961331, "min": 0.57592}, "location": {"width": 808, "top": 1531, "height": 32, "left": 199}, "words": "的研究中,应用癌症治疗功能评价量表(FACT-L)进行QQL价,包括生理"}, {"probability": {"variance": 0.000238, "average": 0.947448, "min": 0.932013}, "location": {"width": 227, "top": 1594, "height": 45, "left": 728}, "words": "贸易"}, {"probability": {"variance": 0.062092, "average": 0.823823, "min": 0.393579}, "location": {"width": 236, "top": 1621, "height": 63, "left": 723}, "words": "有限公"}], "language": 3}